Literature DB >> 28323122

Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination.

Sílvia Vilarinho1, E Zeynep Erson-Omay2, Kisha Mitchell-Richards3, Charles Cha4, Carol Nelson-Williams5, Akdes Serin Harmancı2, Katsuhito Yasuno2, Murat Günel6, Tamar H Taddei7.   

Abstract

Hepatocellular adenoma (HCA) is a rare benign liver tumor, predominantly seen in young women. Its major complications are malignant transformation, spontaneous hemorrhage, and rupture. We describe a case of a young female with no underlying liver disease who presented with acute abdominal pain and was found to have a 17cm heterogeneous mass in the left lobe of the liver. She underwent left hepatectomy and pathology revealed a 14cm moderately differentiated hepatocellular carcinoma (HCC) arising in a shell of a HCA. At that time, vascular invasion was already present. She rapidly developed recurrent multifocal hepatic lesions and subsequent spread to the brain, leading to her death 18months after surgery. To investigate the underlying genetic events occurring during hepatocellular adenoma-carcinoma transition and extra-hepatic dissemination, we performed whole exome sequencing of DNA isolated from peripheral blood leucocytes, HCA, HCC, tumor thrombus and brain metastasis. Our data show a step-wise addition of somatic mutations and copy number variations with disease progression, suggesting a linear tumor evolution, which is supported by clonality analysis. Specifically, using a model based clustering of somatic mutations, one single founding clone arising in the HCA, which included catenin beta 1 (CTNNB1) and IL6ST driver mutations, was identified and displayed an increasing clonality rate in HCC, tumor thrombus and brain metastasis. Our data highlight the feasibility of performing whole exome capture, sequencing and analysis using formalin-fixed paraffin-embedded (FFPE) samples, and we describe the first genomic longitudinal study of hepatocellular adenoma-carcinoma transition, vascular invasion and brain metastasis with detailed clinicopathologic annotation.
Copyright © 2017 European Association for the Study of the Liver. All rights reserved.

Entities:  

Keywords:  Brain metastasis; FFPE tissue molecular analysis; Hepatocellular adenoma; Hepatocellular adenoma-carcinoma transition; Hepatocellular carcinoma; Whole exome sequencing

Mesh:

Year:  2017        PMID: 28323122      PMCID: PMC5497691          DOI: 10.1016/j.jhep.2017.03.009

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  20 in total

1.  GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.

Authors:  Jean Charles Nault; Monique Fabre; Gabrielle Couchy; Camilla Pilati; Emmanuelle Jeannot; Jeanne Tran Van Nhieu; Marie-Christine Saint-Paul; Anne De Muret; Marie-José Redon; Catherine Buffet; Sylvie Salenave; Charles Balabaud; Sophie Prevot; Philippe Labrune; Paulette Bioulac-Sage; Jean-Yves Scoazec; Philippe Chanson; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2011-08-09       Impact factor: 25.083

2.  Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis.

Authors:  E Zeynep Erson-Omay; Ahmet Okay Çağlayan; Nikolaus Schultz; Nils Weinhold; S Bülent Omay; Koray Özduman; Yavuz Köksal; Jie Li; Akdes Serin Harmancı; Victoria Clark; Geneive Carrión-Grant; Jacob Baranoski; Caner Çağlar; Tanyeri Barak; Süleyman Coşkun; Burçin Baran; Doğan Köse; Jia Sun; Mehmet Bakırcıoğlu; Jennifer Moliterno Günel; M Necmettin Pamir; Ketu Mishra-Gorur; Kaya Bilguvar; Katsuhito Yasuno; Alexander Vortmeyer; Anita J Huttner; Chris Sander; Murat Günel
Journal:  Neuro Oncol       Date:  2015-03-03       Impact factor: 12.300

3.  Bi-allelic inactivation of TCF1 in hepatic adenomas.

Authors:  Olivier Bluteau; Emmanuelle Jeannot; Paulette Bioulac-Sage; Juan Martin Marqués; Jean-Frédéric Blanc; Hung Bui; Jean-Christophe Beaudoin; Dominique Franco; Charles Balabaud; Pierre Laurent-Puig; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2002-09-23       Impact factor: 38.330

4.  Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations.

Authors:  Sílvia Vilarinho; E Zeynep Erson-Omay; Akdes Serin Harmanci; Raffaella Morotti; Geneive Carrion-Grant; Jacob Baranoski; A S Knisely; Udeme Ekong; Sukru Emre; Katsuhito Yasuno; Kaya Bilguvar; Murat Günel
Journal:  J Hepatol       Date:  2014-07-10       Impact factor: 25.083

5.  Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.

Authors:  Priscilla K Brastianos; Scott L Carter; Gad Getz; William C Hahn; Sandro Santagata; Daniel P Cahill; Amaro Taylor-Weiner; Robert T Jones; Eliezer M Van Allen; Michael S Lawrence; Peleg M Horowitz; Kristian Cibulskis; Keith L Ligon; Josep Tabernero; Joan Seoane; Elena Martinez-Saez; William T Curry; Ian F Dunn; Sun Ha Paek; Sung-Hye Park; Aaron McKenna; Aaron Chevalier; Mara Rosenberg; Frederick G Barker; Corey M Gill; Paul Van Hummelen; Aaron R Thorner; Bruce E Johnson; Mai P Hoang; Toni K Choueiri; Sabina Signoretti; Carrie Sougnez; Michael S Rabin; Nancy U Lin; Eric P Winer; Anat Stemmer-Rachamimov; Matthew Meyerson; Levi Garraway; Stacey Gabriel; Eric S Lander; Rameen Beroukhim; Tracy T Batchelor; Jose Baselga; David N Louis
Journal:  Cancer Discov       Date:  2015-09-26       Impact factor: 39.397

6.  Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.

Authors:  Sandra Rebouissou; Mohamed Amessou; Gabrielle Couchy; Karine Poussin; Sandrine Imbeaud; Camilla Pilati; Tina Izard; Charles Balabaud; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  Nature       Date:  2008-11-19       Impact factor: 49.962

7.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

8.  Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.

Authors:  Camilla Pilati; Mohamed Amessou; Michel P Bihl; Charles Balabaud; Jeanne Tran Van Nhieu; Valérie Paradis; Jean Charles Nault; Tina Izard; Paulette Bioulac-Sage; Gabrielle Couchy; Karine Poussin; Jessica Zucman-Rossi
Journal:  J Exp Med       Date:  2011-06-20       Impact factor: 14.307

9.  Plexin-B2 promotes invasive growth of malignant glioma.

Authors:  Audrey P Le; Yong Huang; Sandeep C Pingle; Santosh Kesari; Huaien Wang; Raymund L Yong; Hongyan Zou; Roland H Friedel
Journal:  Oncotarget       Date:  2015-03-30

10.  Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

Authors:  Eliezer M Van Allen; Nikhil Wagle; Petar Stojanov; Danielle L Perrin; Kristian Cibulskis; Sara Marlow; Judit Jane-Valbuena; Dennis C Friedrich; Gregory Kryukov; Scott L Carter; Aaron McKenna; Andrey Sivachenko; Mara Rosenberg; Adam Kiezun; Douglas Voet; Michael Lawrence; Lee T Lichtenstein; Jeff G Gentry; Franklin W Huang; Jennifer Fostel; Deborah Farlow; David Barbie; Leena Gandhi; Eric S Lander; Stacy W Gray; Steven Joffe; Pasi Janne; Judy Garber; Laura MacConaill; Neal Lindeman; Barrett Rollins; Philip Kantoff; Sheila A Fisher; Stacey Gabriel; Gad Getz; Levi A Garraway
Journal:  Nat Med       Date:  2014-05-18       Impact factor: 53.440

View more
  4 in total

1.  Growing Concerns: A 3-Year-Old Girl with Multiple Hepatic Masses and Gastrointestinal Bleeding.

Authors:  Christine Yang; Adam Gomez; Anshul Haldipur; William Berquist; Dorsey Bass
Journal:  Dig Dis Sci       Date:  2017-06-23       Impact factor: 3.199

Review 2.  Mutational signatures and processes in hepatobiliary cancers.

Authors:  Ekaterina Zhuravleva; Colm J O'Rourke; Jesper B Andersen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-10       Impact factor: 73.082

3.  SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF.

Authors:  Weikai Xiao; Shaoquan Zheng; Xinhua Xie; Xing Li; Lijuan Zhang; Anli Yang; Jian Wang; Hailin Tang; Xiaoming Xie
Journal:  Mol Ther Oncolytics       Date:  2020-03-13       Impact factor: 7.200

4.  Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma.

Authors:  Stine Karlsen Oversoe; Michelle Simone Clement; Britta Weber; Henning Grønbæk; Stephen Jacques Hamilton-Dutoit; Boe Sandahl Sorensen; Jens Kelsen
Journal:  BMC Cancer       Date:  2021-04-08       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.